Opinion: FDA needs to fully review ACAM2000 before allowing its widespread use as a monkeypox vaccine
As the United States grapples with monkeypox, which has been declared a public health emergency, one of the key strategies that will be used to control its spread is vaccinating high-risk individuals.
Demand for monkeypox vaccine far exceeds the supply.
